Cargando…

Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil

To rigorously explore the role of omega-3 polyunsaturated fatty acids (PUFA) in the treatment of diabetic peripheral neuropathy (DPN), we have created a transgenic mouse utilizing a Cre-lox promoter to control overexpression of human 15-lipoxygenase-1 (15-LOX-1). In this study, we sought to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppey, Lawrence, Obrosov, Alexander, Shevalye, Hanna, Davidson, Eric, Paradee, William, Yorek, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987465/
https://www.ncbi.nlm.nih.gov/pubmed/33816635
http://dx.doi.org/10.1155/2021/5564477
_version_ 1783668617018081280
author Coppey, Lawrence
Obrosov, Alexander
Shevalye, Hanna
Davidson, Eric
Paradee, William
Yorek, Mark A.
author_facet Coppey, Lawrence
Obrosov, Alexander
Shevalye, Hanna
Davidson, Eric
Paradee, William
Yorek, Mark A.
author_sort Coppey, Lawrence
collection PubMed
description To rigorously explore the role of omega-3 polyunsaturated fatty acids (PUFA) in the treatment of diabetic peripheral neuropathy (DPN), we have created a transgenic mouse utilizing a Cre-lox promoter to control overexpression of human 15-lipoxygenase-1 (15-LOX-1). In this study, we sought to determine the effect of treating type 2 diabetic wild-type mice and transgenic mice ubiquitously overexpressing 15-LOX-1 with menhaden oil on endpoints related to DPN. Wild-type and transgenic mice on a C57Bl/6J background were divided into three groups. Two of each of these groups were used to create a high-fat diet/streptozotocin model for type 2 diabetes. The remaining mice were control groups. Four weeks later, one set of diabetic mice from each group was treated with menhaden oil for twelve weeks and then evaluated using DPN-related endpoints. Studies were also performed using dorsal root ganglion neurons isolated from wild-type and transgenic mice. Wild-type and transgenic diabetic mice developed DPN as determined by slowing of nerve conduction velocity, decreased sensory nerve fibers in the skin and cornea, and impairment of thermal and mechanical sensitivity of the hindpaw compared to their respective control mice. Although not significant, there was a trend for the severity of these DPN-related deficits to be less in the diabetic transgenic mice compared to the diabetic wild-type mice. Treating diabetic wild-type and transgenic mice with menhaden oil improved the DPN-related endpoints with a trend for greater improvement or protection by menhaden oil observed in the diabetic transgenic mice. Treating dorsal root ganglion neurons with docosahexanoic acid but not eicosapentaenoic acid significantly increased neurite outgrowth with greater efficacy observed with neurons isolated from transgenic mice. Targeting pathways that will increase the production of the anti-inflammatory metabolites of omega-3 PUFA may be an efficacious approach to developing an effective treatment for DPN.
format Online
Article
Text
id pubmed-7987465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79874652021-04-02 Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil Coppey, Lawrence Obrosov, Alexander Shevalye, Hanna Davidson, Eric Paradee, William Yorek, Mark A. J Diabetes Res Research Article To rigorously explore the role of omega-3 polyunsaturated fatty acids (PUFA) in the treatment of diabetic peripheral neuropathy (DPN), we have created a transgenic mouse utilizing a Cre-lox promoter to control overexpression of human 15-lipoxygenase-1 (15-LOX-1). In this study, we sought to determine the effect of treating type 2 diabetic wild-type mice and transgenic mice ubiquitously overexpressing 15-LOX-1 with menhaden oil on endpoints related to DPN. Wild-type and transgenic mice on a C57Bl/6J background were divided into three groups. Two of each of these groups were used to create a high-fat diet/streptozotocin model for type 2 diabetes. The remaining mice were control groups. Four weeks later, one set of diabetic mice from each group was treated with menhaden oil for twelve weeks and then evaluated using DPN-related endpoints. Studies were also performed using dorsal root ganglion neurons isolated from wild-type and transgenic mice. Wild-type and transgenic diabetic mice developed DPN as determined by slowing of nerve conduction velocity, decreased sensory nerve fibers in the skin and cornea, and impairment of thermal and mechanical sensitivity of the hindpaw compared to their respective control mice. Although not significant, there was a trend for the severity of these DPN-related deficits to be less in the diabetic transgenic mice compared to the diabetic wild-type mice. Treating diabetic wild-type and transgenic mice with menhaden oil improved the DPN-related endpoints with a trend for greater improvement or protection by menhaden oil observed in the diabetic transgenic mice. Treating dorsal root ganglion neurons with docosahexanoic acid but not eicosapentaenoic acid significantly increased neurite outgrowth with greater efficacy observed with neurons isolated from transgenic mice. Targeting pathways that will increase the production of the anti-inflammatory metabolites of omega-3 PUFA may be an efficacious approach to developing an effective treatment for DPN. Hindawi 2021-03-15 /pmc/articles/PMC7987465/ /pubmed/33816635 http://dx.doi.org/10.1155/2021/5564477 Text en Copyright © 2021 Lawrence Coppey et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Coppey, Lawrence
Obrosov, Alexander
Shevalye, Hanna
Davidson, Eric
Paradee, William
Yorek, Mark A.
Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title_full Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title_fullStr Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title_full_unstemmed Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title_short Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
title_sort characterization of mice ubiquitously overexpressing human 15-lipoxygenase-1: effect of diabetes on peripheral neuropathy and treatment with menhaden oil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987465/
https://www.ncbi.nlm.nih.gov/pubmed/33816635
http://dx.doi.org/10.1155/2021/5564477
work_keys_str_mv AT coppeylawrence characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil
AT obrosovalexander characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil
AT shevalyehanna characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil
AT davidsoneric characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil
AT paradeewilliam characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil
AT yorekmarka characterizationofmiceubiquitouslyoverexpressinghuman15lipoxygenase1effectofdiabetesonperipheralneuropathyandtreatmentwithmenhadenoil